“Chronic viral infection and cancer, openings for vaccines”
December 16-17, 2021
We are happy to share with you the information on the continued activities TECHVAC Network in the field of research meetings devoted to modern problems of vaccinology, acute and chronic viral infections, cancer associated with viral infections and approaches to develoment of novel vaccines and immunotherapies for this conditions.
First held in November 2016, vaccine conferences bring together specialists from all over the world including researchers, both advanced and early carrier investigators, healthcare professionals, government officials, and industry representatives from the many disciplines of vaccinology field.
Our latest activity was the International On-line Symposium “Chronic viral infections and cancer, openings for vaccines” held December 16-17, 2021. It brought together almost 100 participants from 12 countries including Russia, Sweden, Latvia, Italy, France, Ireland, Norway, Spain, Germany, USA, South Africa and South Korea, in a tight program with 13 plenary lectures, 29 oral and 9 poster presentations.
Symposium was organized and supported by the International Society for Vaccines, Riga Stradins University (Riga, Latvia), Gamaleya National Research Center for Epidemiology and Microbiology (Moscow, Russia), Peoples Friendship University (Moscow, Russia), international journals INFECTIOUS AGENTS AND CANCER (BMC) and CANCERS (MDPI), and Papilloma Society (Russia).
Symposium unravelled the progress in the studies of the molecular pathogenesis of chronic viral infections, cover common mechanisms of action of human oncogenic viruses, such as the activity of viral oncoproteins, induction of genomic instability, support of chronic inflammation, and modulation of tumor microenvironment. Special attention will be devoted to virus-induced alterations in the functions of immune system, induction of innate and adaptive immune responses including the relationship between metabolism and the immune response to viral infections, and immunometabolism on the cellular level. In-depth understanding of these processes would create new openings to the design of novel viral vaccines and immunotherapies.
Most of the presentations are available as PDF or PPT files with links in the conference program https://techvac.org/online-symposium-chronic-viral-infections-and-cancer-openings-for-vaccines/ To open, please, click on the word “presentation” in blue after presentation title.
Abstracts and report on the symposium are currently prepared for publication in a supplementary issue of INFECTIOUS AGENTS AND CANCER, BMC journal (Springer Nature), Q2 in Infectious Diseases; IF Web of Science 2.7; IF Scopus 4.3. We will invite you to proof-read the issue.
Full length studies and reviews are invited for submission into special issue of CANCERS https://www.mdpi.com/journal/cancers (MDPI, Q1, IF 6.63) “Chronic viral infections and cancer, openings for immunotherapies and vaccines”. If you are interested to submit, please, send an email inquiry to Dr Maria Isaguliants (firstname.lastname@example.org) who will serve as the editor for this issue together with Prof Franco Buonaguro and Dr Alexander Ivanov.
On the opening page of TECHVAC Network web, you can see who won the contest for the best presentations by early carrier researchers. Winners received the prize and vouchers for two free publications in CANCERS, and one in INFECTIOUS AGENTS AND CANCER.
On behalf of the Program and Organizing Committees of Symposium “CHRONIC VIRAL INFECTIONS AND CANCER, OPENING FOR VACCINES” we would like to cordially thank you for the participation in this event, and your input in the presented studies and their discussion. We hope that it was fruitful for you.
We would be grateful for your opinions and comments on this meeting, and rely on you joining us in our future events.
The nearest would be International Conference “PERSPECTIVE TECHNOLOGIES IN VACCINATION AND IMMUNOTHERAPY” TECHVAC2022 planned for late autumn 2022. The format – live, or on-line, or hybrid will depend on the epidemiological situation. For further info, please, follow our web-site www.techvac.org.
With kind regards
Maria Isaguliants & Franco M Buonaguro,
ANNOUNCEMENT OF WINNERS OF THE CONTEST FOR THE BEST PRESENTATIONS BY EARLY CARRIER RESEARCHERS click the link https://techvac.org/announcement/
Previous TECHVAC Events: click the link https://techvac.org/previous-techvac-events/